Classification of evidence in decision-analytic models of cost-effectiveness: A content analysis of published reports

被引:12
|
作者
Paisley, Suzy [1 ]
机构
[1] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England
关键词
Cost-benefit analysis; Models; Economic; Information storage and retrieval; ECONOMIC-EVALUATION; CANCER;
D O I
10.1017/S026646231000098X
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: The aim of this study was to assess systematically the scope of evidence and purposes for which evidence is used in decision-analytic models of cost-effectiveness and to assess the implications for search methods. Methods: A content analysis of published reports of models was undertaken. Details of cited sources were extracted and categorized according to three dimensions; type of information provided by the evidence, type of source from which the evidence was drawn and type of modeling activity supported by the evidence. The analysis was used to generate a classification of evidence. Relationships within and between the categories within the classification were sought and the implications for searching considered. Results: The classification generated fourteen types of information, seven types of sources of evidence and five modeling activities supported by evidence. A broad range of evidence was identified drawn from a diverse range of sources including both research-based and non research-based sources. The use of evidence was not restricted to the population of model parameters but was used to inform the development of the modeling framework and to justify the analytical and methodological approach. Conclusions: Decision-analytic models use evidence to support all aspects of model development. The classification of evidence defines in depth the role of evidence in modeling. It can be used to inform the systematic identification of evidence.
引用
收藏
页码:458 / 462
页数:5
相关论文
共 50 条
  • [41] Novel strategies to prevent retained surgical sponges: A decision-analytic model predicting relative cost-effectiveness
    Regenbogen, Scott E.
    Greenberg, Caprice C.
    Resch, Stepben C.
    Kollengode, Anantha
    Cima, Robert R.
    Zinner, Michael J.
    Gawande, Atul A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (03) : S73 - S74
  • [42] Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
    Tang, Jianjun
    Liang, Yuanbo
    O'Neill, Ciaran
    Kee, Frank
    Jiang, Junhong
    Congdon, Nathan
    LANCET GLOBAL HEALTH, 2019, 7 (07): : E968 - E978
  • [43] Cost-effectiveness and cost-utility of population-based glaucoma screening in China: A decision-analytic Markov model
    Congdon, Nathan G.
    Tang, Jianjun
    Liang, Yuanbo
    O'Neill, Ciaran
    Kee, Frank
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [44] MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES
    ECKMAN, MH
    LEVINE, HJ
    PAUKER, SG
    CHEST, 1995, 108 (04) : S457 - S470
  • [45] Development and validation of a new decision-analytic model designed to evaluate the cost-effectiveness of cardiac resynchronisation therapy
    Gras, D
    Banz, K
    EUROPEAN HEART JOURNAL, 2003, 24 : 519 - 519
  • [46] Long-term effectiveness and cost-effectiveness of disease management programs in congestive heart failure: A decision-analytic view
    Gohler, A
    Osterziel, KJ
    Siebert, U
    CIRCULATION, 2004, 110 (17) : 639 - 639
  • [47] Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes
    Smare, Caitlin
    Lakhdari, Khalid
    Doan, Justin
    Posnett, John
    Johal, Sukhvinder
    PHARMACOECONOMICS, 2020, 38 (01) : 97 - 108
  • [48] Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes
    Caitlin Smare
    Khalid Lakhdari
    Justin Doan
    John Posnett
    Sukhvinder Johal
    PharmacoEconomics, 2020, 38 : 97 - 108
  • [49] A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models
    Chase Hollman
    Mike Paulden
    Petros Pechlivanoglou
    Christopher McCabe
    PharmacoEconomics, 2017, 35 : 817 - 830
  • [50] A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models
    Hollman, Chase
    Paulden, Mike
    Pechlivanoglou, Petros
    McCabe, Christopher
    PHARMACOECONOMICS, 2017, 35 (08) : 817 - 830